Search

everythinglearnresearchcommunity

for

Search:↓

QR 678 and QR678 Neo treatments are effective for hair loss in women with PCOS.

Two gene variations, rs6493497 and rs7176005, may be linked to female hair loss in Chinese people.

Male tissue has more cell death than female tissue after ischemia, and some neurosteroids only protect female cells.

Women with PCOS often have insulin resistance, abnormal lipid levels, and a higher risk of diabetes and heart disease; lifestyle changes and medication like metformin can help manage these risks.

Children receive less than half of recommended health care, and routine hormonal testing for female-pattern hair loss is unnecessary without other androgen excess symptoms.

Women with PCOS often have metabolic issues like insulin resistance and a higher risk of diabetes and abnormal lipid levels.

Most women with excessive hair growth have PCOS; treatment varies and focuses on preventing new hair, with electrolysis as the only permanent removal method.

Non-binary transgender individuals need personalized hormonal treatments for better well-being and quality of life.

The document concludes that diagnosing PCOS in teenagers is difficult and should focus on specific hormone levels and menstrual irregularities, while also considering treatment for symptoms and related health issues.

Eating a Mediterranean diet and taking certain supplements may improve symptoms of PCOS.

5α-reductase inhibitors help treat disorders caused by DHT and have potential for future therapies.

Dehydroepiandrosterone (DHEA) is a prohormone important for producing sex steroids and has potential health benefits.

Aging-related hormone changes affect voice quality, especially during puberty, menstruation, pregnancy, and menopause.

The document concludes that understanding hair follicle histology and the hair cycle is crucial for diagnosing alopecia.

A woman's excessive hair growth and masculine features were due to a rare benign ovarian tumor and endometrial cancer, which improved after surgery.

The document concludes that recognizing and properly diagnosing lipodystrophy syndromes is crucial for effective management and treatment.

Early treatment helps stop hair loss in women of color.

The document likely offers guidance on treating a woman's excessive hair growth, considering her symptoms and obesity.

Sex hormones may influence COVID-19 severity, with males at higher risk, and certain hormone therapies could potentially treat the virus.

Polycystic ovary syndrome causes chronic inflammation affecting all body systems, but proper nutrition, exercise, and supplements can improve the condition.

The combination therapy improved PCOS symptoms in both obese and non-obese women, with weight loss in the obese group.

Sex hormones like estrogen and testosterone may affect COVID-19 severity differently in men and women, potentially influencing prevention and treatment strategies.

Postmenopausal women with hyperandrogenism didn't have better metabolic health even after their testosterone levels became normal.

Certain gene variants may contribute to high androgen levels in women with polycystic ovary syndrome.

The document concludes that proper diagnosis and combined treatments are key for hirsutism management, and weight loss may help overweight patients.

An mFG score of 7 or higher indicates hirsutism in Filipino women, often linked to higher free testosterone levels.

Women with irregular periods have a higher risk of heart disease.

The document concludes that more research is needed to fully understand the causes of PCOS.

PCOS is a hormonal disorder causing symptoms like irregular periods and acne, and increases the risk of diabetes and heart disease.

Obese Hispanic women with PCOS are at higher risk for metabolic problems than non-Hispanic white women.